51
van der Pol, Simon, Degener, Fabian, Postma, Maarten J., Vemer, Pepijn
Veröffentlicht in: van der Pol , S , Degener , F , Postma , M J & Vemer , P 2017 , ' An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands ' , Value in Health , vol. 20 , no. 3 , pp. 388-396 . https://doi.org/10.1016/j.jval.2016.10.015;
2017
Veröffentlicht in: van der Pol , S , Degener , F , Postma , M J & Vemer , P 2017 , ' An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands ' , Value in Health , vol. 20 , no. 3 , pp. 388-396 . https://doi.org/10.1016/j.jval.2016.10.015;
2017
52
53
54
55
Roseboom, Kitty J., van Dongen, Johanna M., Tompa, Emile, van Tulder, Maurits W., Bosmans, Judith E.
Veröffentlicht in: Roseboom , K J , van Dongen , J M , Tompa , E , van Tulder , M W & Bosmans , J E 2017 , ' Economic evaluations of health technologies in Dutch healthcare decision-making: a qualitative study of the current and potential use, barriers, and facilitators ' , BMC Health Services Research , vol. 17 , no. 1 , 89 . https://doi.org/10.1186/s12913-017-1986-9;
2017
Veröffentlicht in: Roseboom , K J , van Dongen , J M , Tompa , E , van Tulder , M W & Bosmans , J E 2017 , ' Economic evaluations of health technologies in Dutch healthcare decision-making: a qualitative study of the current and potential use, barriers, and facilitators ' , BMC Health Services Research , vol. 17 , no. 1 , 89 . https://doi.org/10.1186/s12913-017-1986-9;
2017
56
van Baal, Pieter H. M., Feenstra, Talitha L., Polder, Johan J., Hoogenveen, Rudolf T., Brouwer, Werner B. F.
Veröffentlicht in: van Baal , P H M , Feenstra , T L , Polder , J J , Hoogenveen , R T & Brouwer , W B F 2011 , ' ECONOMIC EVALUATION AND THE POSTPONEMENT OF HEALTH CARE COSTS ' , Health Economics , vol. 20 , no. 4 , pp. 432-445 . https://doi.org/10.1002/hec.1599;
2011
Veröffentlicht in: van Baal , P H M , Feenstra , T L , Polder , J J , Hoogenveen , R T & Brouwer , W B F 2011 , ' ECONOMIC EVALUATION AND THE POSTPONEMENT OF HEALTH CARE COSTS ' , Health Economics , vol. 20 , no. 4 , pp. 432-445 . https://doi.org/10.1002/hec.1599;
2011
57
Geenen, Joost W., Boersmaz, Cornelis, Klungel, Olaf H., Hovels, Anke M.
Veröffentlicht in: Geenen , J W , Boersmaz , C , Klungel , O H & Hovels , A M 2019 , ' Accuracy of budget impact estimations and impact on patient access : a hepatitis C case study ' , European Journal of Health Economics , vol. 20 , no. 6 , pp. 857-867 . https://doi.org/10.1007/s10198-019-01048-z;
2019
Veröffentlicht in: Geenen , J W , Boersmaz , C , Klungel , O H & Hovels , A M 2019 , ' Accuracy of budget impact estimations and impact on patient access : a hepatitis C case study ' , European Journal of Health Economics , vol. 20 , no. 6 , pp. 857-867 . https://doi.org/10.1007/s10198-019-01048-z;
2019
58
van den Berg, Bernard, Gafni, Amiram, Portrait, France
Veröffentlicht in: van den Berg , B , Gafni , A & Portrait , F 2017 , ' Attributing a monetary value to patients' time : A contingent valuation approach ' , Social Science & Medicine , vol. 179 , pp. 182-190 . https://doi.org/10.1016/j.socscimed.2017.02.025;
2017
Veröffentlicht in: van den Berg , B , Gafni , A & Portrait , F 2017 , ' Attributing a monetary value to patients' time : A contingent valuation approach ' , Social Science & Medicine , vol. 179 , pp. 182-190 . https://doi.org/10.1016/j.socscimed.2017.02.025;
2017
59
Westra, Tjalke A., de Vries, Robin, Tamminga, Johannes J., Sauboin, Christophe J., Postma, Maarten J.
Veröffentlicht in: Westra , T A , de Vries , R , Tamminga , J J , Sauboin , C J & Postma , M J 2010 , ' Cost-Effectiveness Analysis of Various Pertussis Vaccination Strategies Primarily Aimed at Protecting Infants in the Netherlands ' , Clinical Therapeutics , vol. 32 , no. 8 , pp. 1479-1495 . https://doi.org/10.1016/j.clinthera.2010.07.017;
2010
Veröffentlicht in: Westra , T A , de Vries , R , Tamminga , J J , Sauboin , C J & Postma , M J 2010 , ' Cost-Effectiveness Analysis of Various Pertussis Vaccination Strategies Primarily Aimed at Protecting Infants in the Netherlands ' , Clinical Therapeutics , vol. 32 , no. 8 , pp. 1479-1495 . https://doi.org/10.1016/j.clinthera.2010.07.017;
2010
60
Westra, Tjalke A., Stirbu-Wagner, Irina, Dorsman, Sara, Tutuhatunewa, Eric D., de Vrij, Edwin L., Nijman, Hans W., Daemen, Toos, Wilschut, Jan C., Postma, Maarten J.
Veröffentlicht in: Westra , T A , Stirbu-Wagner , I , Dorsman , S , Tutuhatunewa , E D , de Vrij , E L , Nijman , H W , Daemen , T , Wilschut , J C & Postma , M J 2013 , ' Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands ' , BMC Infectious Diseases , vol. 13 , no. 1 , 75 . https://doi.org/10.1186/1471-2334-13-75;
2013
Veröffentlicht in: Westra , T A , Stirbu-Wagner , I , Dorsman , S , Tutuhatunewa , E D , de Vrij , E L , Nijman , H W , Daemen , T , Wilschut , J C & Postma , M J 2013 , ' Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands ' , BMC Infectious Diseases , vol. 13 , no. 1 , 75 . https://doi.org/10.1186/1471-2334-13-75;
2013